Elserafy Noha, Thompson Sue, Dalkeith Troy, Stormon Michael, Thomas Gordon, Shun Albert, Sawyer Janine, Balasubramanian Shanti, Bhattacharya Kaustuv, Badawi Nadia, Ellaway Carolyn
Genetic Metabolic Disorders Service, The Children's Hospital at Westmead Sydney Children's Hospital Network Sydney New South Wales Australia.
Paediatric divison The University of Sydney Sydney New South Wales Australia.
JIMD Rep. 2021 May 4;60(1):88-95. doi: 10.1002/jmd2.12219. eCollection 2021 Jul.
Inborn errors of metabolism (IEM) are a diverse group of genetic disorders that can result in significant morbidity and sometimes death. Metabolic management can be challenging and burdensome for families. Liver transplantation (LT) is increasingly being considered a treatment option for some IEMs. IEMs are now considered the second most common reason for pediatric LT.
To review the data of all children with an IEM who had LT at The Children's Hospital at Westmead (CHW), NSW, Australia between January 1986 and January 2019.
Retrospective data collected from the medical records and genetic files included patient demographics, family history, parental consanguinity, method of diagnosis of IEM, hospital and intensive care unit admissions, age at LT, graft type, clinical outcomes and metabolic management pre and post-LT.
Twenty-four LT were performed for 21 patients. IEM diagnoses were MSUD (n = 4), UCD (n = 8), OA (n = 6), TYR type I (n = 2) and GSD Ia (n = 1). Three patients had repeat transplants due to complications. Median age at transplant was 6.21 years (MSUD), 0.87 years (UCD), 1.64 years (OA) and 2.2 years (TYR I). Two patients died peri-operatively early in the series, one died 3 months after successful LT due to septicemia. Eighteen LTs have been performed since 2008 in comparison to six LT prior to 2008. Dietary management was liberalized post LT for all patients.
Referral for LT for IEMs has increased over the last 33 years, with the most referrals in the last 10 years. Early LT has resulted in improved clinical outcomes and patient survival.
先天性代谢缺陷(IEM)是一组多样的遗传疾病,可导致严重发病,有时甚至死亡。代谢管理对家庭来说可能具有挑战性且负担沉重。肝移植(LT)越来越被视为某些IEM的一种治疗选择。IEM现在被认为是儿童LT的第二大常见原因。
回顾1986年1月至2019年1月期间在澳大利亚新南威尔士州韦斯特米德儿童医院(CHW)接受LT的所有IEM患儿的数据。
从病历和基因档案中收集的回顾性数据包括患者人口统计学、家族史、父母近亲结婚情况、IEM诊断方法、住院和重症监护病房入院情况、LT时的年龄、移植物类型、临床结果以及LT前后的代谢管理情况。
对21例患者进行了24次LT。IEM诊断包括枫糖尿症(MSUD,n = 4)、尿素循环障碍(UCD,n = 8)、鸟氨酸氨甲酰转移酶缺乏症(OA,n = 6)、I型酪氨酸血症(TYR I,n = 2)和糖原贮积病Ia型(GSD Ia,n = 1)。3例患者因并发症接受了再次移植。移植时的中位年龄分别为6.21岁(MSUD)、0.87岁(UCD)、1.64岁(OA)和2.2岁(TYR I)。该系列中有2例患者在围手术期早期死亡,1例在LT成功后3个月因败血症死亡。与200